225 related articles for article (PubMed ID: 20978204)
1. Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL.
Yang Y; Ren Y; Ramani VC; Nan L; Suva LJ; Sanderson RD
Cancer Res; 2010 Nov; 70(21):8329-38. PubMed ID: 20978204
[TBL] [Abstract][Full Text] [Related]
2. High heparanase activity in multiple myeloma is associated with elevated microvessel density.
Kelly T; Miao HQ; Yang Y; Navarro E; Kussie P; Huang Y; MacLeod V; Casciano J; Joseph L; Zhan F; Zangari M; Barlogie B; Shaughnessy J; Sanderson RD
Cancer Res; 2003 Dec; 63(24):8749-56. PubMed ID: 14695190
[TBL] [Abstract][Full Text] [Related]
3. Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease.
Ruan J; Trotter TN; Nan L; Luo R; Javed A; Sanderson RD; Suva LJ; Yang Y
Bone; 2013 Nov; 57(1):10-7. PubMed ID: 23895995
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.
Sanderson RD; Yang Y; Suva LJ; Kelly T
Matrix Biol; 2004 Oct; 23(6):341-52. PubMed ID: 15533755
[TBL] [Abstract][Full Text] [Related]
5. Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis.
Cao H; Zhu K; Qiu L; Li S; Niu H; Hao M; Yang S; Zhao Z; Lai Y; Anderson JL; Fan J; Im HJ; Chen D; Roodman GD; Xiao G
J Biol Chem; 2013 Oct; 288(42):30399-30410. PubMed ID: 24005670
[TBL] [Abstract][Full Text] [Related]
6. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease.
Giuliani N; Colla S; Sala R; Moroni M; Lazzaretti M; La Monica S; Bonomini S; Hojden M; Sammarelli G; Barillè S; Bataille R; Rizzoli V
Blood; 2002 Dec; 100(13):4615-21. PubMed ID: 12393684
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.
Yang J; He J; Wang J; Cao Y; Ling J; Qian J; Lu Y; Li H; Zheng Y; Lan Y; Hong S; Matthews J; Starbuck MW; Navone NM; Orlowski RZ; Lin P; Kwak LW; Yi Q
Leukemia; 2012 Sep; 26(9):2114-23. PubMed ID: 22425892
[TBL] [Abstract][Full Text] [Related]
8. Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation.
Lai FP; Cole-Sinclair M; Cheng WJ; Quinn JM; Gillespie MT; Sentry JW; Schneider HG
Br J Haematol; 2004 Jul; 126(2):192-201. PubMed ID: 15238139
[TBL] [Abstract][Full Text] [Related]
9. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.
Ohba T; Cole HA; Cates JM; Slosky DA; Haro H; Ando T; Schwartz HS; Schoenecker JG
J Bone Miner Res; 2014 Jun; 29(6):1431-45. PubMed ID: 24443409
[TBL] [Abstract][Full Text] [Related]
11. The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells.
Tsubaki M; Seki S; Takeda T; Chihara A; Arai Y; Morii Y; Imano M; Satou T; Shimomura K; Nishida S
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114380
[TBL] [Abstract][Full Text] [Related]
12. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
13. Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro.
Tucci M; Ciavarella S; Strippoli S; Brunetti O; Dammacco F; Silvestris F
Exp Hematol; 2011 Jul; 39(7):773-83.e1. PubMed ID: 21569821
[TBL] [Abstract][Full Text] [Related]
14. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis.
Grimaud E; Soubigou L; Couillaud S; Coipeau P; Moreau A; Passuti N; Gouin F; Redini F; Heymann D
Am J Pathol; 2003 Nov; 163(5):2021-31. PubMed ID: 14578201
[TBL] [Abstract][Full Text] [Related]
15. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.
Qiang YW; Chen Y; Stephens O; Brown N; Chen B; Epstein J; Barlogie B; Shaughnessy JD
Blood; 2008 Jul; 112(1):196-207. PubMed ID: 18305214
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis.
Nannuru KC; Futakuchi M; Sadanandam A; Wilson TJ; Varney ML; Myers KJ; Li X; Marcusson EG; Singh RK
Clin Exp Metastasis; 2009; 26(7):797-808. PubMed ID: 19590968
[TBL] [Abstract][Full Text] [Related]
17. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
[TBL] [Abstract][Full Text] [Related]
18. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
19. Ewing sarcoma cells express RANKL and support osteoclastogenesis.
Taylor R; Knowles HJ; Athanasou NA
J Pathol; 2011 Oct; 225(2):195-202. PubMed ID: 21547906
[TBL] [Abstract][Full Text] [Related]
20. Heparanase promotes the spontaneous metastasis of myeloma cells to bone.
Yang Y; Macleod V; Bendre M; Huang Y; Theus AM; Miao HQ; Kussie P; Yaccoby S; Epstein J; Suva LJ; Kelly T; Sanderson RD
Blood; 2005 Feb; 105(3):1303-9. PubMed ID: 15471949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]